Dr. Ifeatu Uchenna Oti, MD

Dr. Oti practices at CHRISTUS Mother Frances Hospital - Tyler in Tyler, Texas, part of CHRISTUS Health.

Dr. Oti's NPI, 1003087388, was assigned on March 14, 2008. Dr. Oti graduated from University of Nigeria Faculty of Medicine in 2001. Dr. Oti's Texas license number on file is N5305.

Dr. Oti's primary practice is CHRISTUS Mother Frances Hospital - Tyler, at 800 East Dawson, Tyler, TX 75701 in Smith County. The practice phone is (903) 593-8441.

Dr. Oti's primary practice is CHRISTUS Mother Frances Hospital - Tyler in Tyler, Texas, part of CHRISTUS Health. Dr. Oti is also affiliated with UT Health Tyler. The medical group on file is The Centers for Kidney Care. Dmand AI also links Dr. Oti to 3 more hospitals, 2 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oti practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Oti's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Oti is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Oti's licenses on file in 5 states: Texas, South Dakota, Oklahoma, Ohio and Pennsylvania.

Dmand AI lists acute kidney failure and chronic kidney disease among the conditions Dr. Oti treats.

CMS data shows 1,937 Medicare services from Dr. Oti across 12 procedure codes in 2024, for 522 Medicare patients. Medicare paid $179,010 for them.

CMS counts 522 Medicare patients who saw Dr. Oti in 2024. The largest group is 75 to 84, with 173 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 22% are also on Medicaid. Their average risk score is 4.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Oti's median patient age at 69, with 49% women.

In 2024, Dr. Oti wrote 1,760 Medicare Part D claims for 282 patients. 84% of them were for generic drugs. CMS names the drug for 1,549 of them, across 33 drugs with 11 or more claims each, at $483,908 in total drug cost. In 2023, CMS named 1,275 claims across 29 drugs.

Dr. Oti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Oti as offering telehealth.

Dmand AI links 1 paper to Dr. Oti. Dr. Oti's most frequent co-author is Kalathil K. Sureshkumar, MD.

Dmand AI links Dr. Oti to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 33 general payments to Dr. Oti from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $167.

Dmand AI lists 1 award for Dr. Oti, most recently CMS Stage 1 2012 in 2012.

Dr. Oti graduated from University of Nigeria Faculty of Medicine in 2001.

Dr. Oti is in network with 23 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.